ABSTRACTS (e-)POSTER PRESENTATIONS
A-138 DEVELOPMENT OF APPROPRIATE AND CULTURALLY ADAPTED EDUCATIONAL TOOLS ON HAEMOPHILIA FOR THE PATIENTS FROM IVORY COAST AND THEIR FAMILIES
C. Lambert, N. Meité, C. Hermans
A-147 DIAGNOSTIC PERFORMANCE EVALUATION OF QUANTIA D-DIMER® REAGENT FOR PULMONARY EMBOLISM IN CLINICAL PRACTICE
R. Harkati, V. Lejeune, P. Lefèvre, J. Freymann
A-120 INFLUENCE OF ENOXAPARIN (CLEXANE®) ON LUPUS ANTICOAGULANT TESTING WITH HEMOSIL DRVVT (IL) AND HEMOSIL SCT (IL) ON ACL TOP
A-S. De Koninck, E. Bailleul
A-121 PERFORMANCES EVALUATION OF A NEW PT REAGENT STA® - NEOPTIMAL FOR PT/INR MEASUREMENT AND EXOGENOUS COAGULATION FACTOR ASSAYS
R. Cupaiolo, M. Blauwaert, J. Yernaux, D. Govaerts, P. Cauchie
A-118 PERFORMANCES EVALUATION OF A NEW COAGULATION ANALYSER, STA R MAX® 2
R. Cupaiolo, I. Courtois, E. Saccomando, D. Govaerts, P. Cauchie
A-119 A PATIENT WITH A TYPE 2 CB VON WILLEBRAND DISEASE: LABORATORY DIAGNOSIS AND RESPONSE TO DESMOPRESSIN
R. Cupaiolo, A. Athanasopoulos, V. Farinella, D. Govaerts, P. Cauchie
A-142 MAJOR AUTOANTIBODY REACTIVITY SEROLOGY AND MINOR SYMPTOMS IN A SLE PATIENT : A CASE REPORT
N. Makki, S. Schouwers, S. Vermeiren, S. Weekx, K. Ver Elst
A-105 PRE-ANALYTICAL STABILITY OF COAGULATION PARAMETERS IN PLASMA STORED AT ROOM TEMPERATURE
E. Linskens, K. Devreese
A-143 ROLE OF VON WILLEBRAND FACTOR IN ABDOMINAL AORTIC ANEURYSMS
I. Portier, L. Desender, K. Martinod, H. Deckmyn, K. VanHoorelbeke, S.F. De Meyer
A-109 A PATIENT WITH ACQUIRED FACTOR X DEFICIENCY AND METASTATIC TRANSITIONAL CELL CARCINOMA OF THE BLADDER : IS THERE A LINK BETWEEN METASTASIS AND FACTOR DEFICIENCY IN SOLID TUMOURS?
T. Cammaert, K. Decaestecker, N. Sundahl, S. Rottey, K. Devreese
A-103 SYSTEMIC THROMBOLYSIS AND ENDOVASCULAR THROMBECTOMY IN SEVERE ACUTE ISCHEMIC STROKE AFTER DABIGATRAN REVERSAL WITH IDARUCIZUMAB
Q. Binet, F. Hammer, O. Rocrelle, A. Peeters, C. Scavée, C. Hermans
A-131 SUCCESSFUL AND COST-EFFECTIVE USE OF FC-FUSED FIX DURING MAJOR ORTHOPAEDIC SURGERY
C. Hermans, E. Thienpont, S. Eeckhoudt, C. Lambert
A-139 ADAMTS13 IN EXPERIMENTAL MALARIA-ASSOCIATED ACUTE RESPIRATORY DISTRESS SYNDROME
S. Kraisin, S. Verhenne, T.-T. Pham, N. VanDePutte, H. Deckmyn, K. VanHoorelbeke, P.E. Van Den Steen, S.F. De Meyer
A-108 MONITORING ISSUES OF DIRECT ANTI-XA ORAL ANTICOAGULANTS AND LOW MOLECULAR WEIGHT HEPARINS, DURING BRIDGING WITH LMWH THERAPY
T. Cammaert, K. Maelegheer, K. Devreese
A-106 DABIGATRAN ETEXILATE IN THE TREATMENT OF LOCALIZED INTRAVASCULAR COAGULOPATHY ASSOCIATED WITH VENOUS MALFORMATIONS
Q. Binet, C. Lambert, C. Hermans
A-133 EFFECT OF ABCB1 GENETIC POLYMORPHISMS ON THE TRANSPORT OF RIVAROXABAN IN HEK293 RECOMBINANT CELL LINES
A.-L. Sennesael, N. Panin, C. Vancraeynest, L. Pochet, A. Spinewine, V. Haufroid, L. Elens
A-107 DIFFERENCES IN HEPARIN AND ENOXAPARIN SENSITIVITY OF THREE COMMERCIALLY AVAILABLE PT REAGENTS
A-S. De Koninck, E. Bailleul
A-123 PLATELETS ARE A MAJOR SOURCE OF PRO-TUMORAL SERUM AMYLOID A PROTEINS DURING INFLAMMATION-INDUCED COLORECTAL CARCINOGENESIS
L. Servais, O. Wéra, J. Dibato Epoh, C. Delierneux, G. Mazzucchelli, D. Baiwir, P. Delvenne, P. Lancellotti, C. Oury
A-122 IS aPTT A GOOD PREDICTOR OF RELIABLE INR IN CHRONIC INTERMITTENT HEMODIALYSIS PATIENTS?
K. Ver Elst, J. Claessens, M. HENCKES, C. SEGHERS, S. Weekx, S. Vermeiren
A-111 IMPACT OF A RAPID CENTRIFUGATION METHOD ON THE ACCURACY OF DIRECT ORAL ANTICOAGULANTS LEVEL AND TURNAROUND TIME
G. Pirard, S. Lessire, L. Pochet, R. Siriez, J. Douxfils, M. Guldenpfennig, J. Baudar, A.-S. Dincq, F. Mullier
A-146 THE EFFECT OF A PNEUMATIC TUBE TRANSPORTATION ON COAGULATION TESTS
L. Moreno Y Banuls, L. Rozen, F. Ponthieux, A. Demulder
ABSTRACTS ORAL PRESENTATIONS
A-126 P2X1 ION CHANNEL REGULATES NEUTROPHIL NETOSIS IN COLITIS
O. Wéra, L. Servais, C. Delierneux, A. Hego, C. Lecut, P. Delvenne, A. Nchimi, P. Lancellotti, C. Oury
A-130 INHIBITING ADAMTS13 ACTIVITY PREVENTS THE LOSS OF HIGH MOLECULAR WEIGHT VWF MULTIMERS IN AN IN VITRO LEFT VENTRICULAR ASSIST DEVICE
S. Deconinck, A. Rauch, E. Roose, N. VanDePutte, C. Tersteeg, H. Deckmyn, S.F. De Meyer, S. Susen, K. VanHoorelbeke
A-135 INCREASED ACETYL-COA CARBOXYLASE PHOSPHORYLATION STATE IN PLATELETS IDENTIFY HIGH RISK PATIENTS WITH CORONARY ARTERY DISEASE: ACCTHEROMA TRIAL
S. Kautbally, S. Lepropre, A. Lerigoleur, C. de Messter, J. Ambroise, J. Kefer, B. Gerber, C. Oury, L. Bertrand, S. Horman, C. Beauloye
A-104 THE INTERACTION OF FACTOR V AND TISSUE FACTOR PATHWAY INHIBITOR IN A MYELOMA PATIENT WITH ACQUIRED FACTOR V DEFICIENCY
E. De Maertelaere, E. Castoldi, I. Van Haute, D. Deeren, K. Devreese
A-127 REVERSAL OF A DABIGATRAN OVERLOAD WITH IDARUCIZUMAB: 5 MG MAY BE A VERY INSUFFICIENT DOSE
P. Cauchie, T. Kimbimbi, J. Van Ryn, M. Piagnerelli
A-132 CRYOPRESERVATION IMPAIRS PLATELET FUNCTION BUT GENERATES PROCOAGULANT PLATELETS
K.R. Six, W. Delabie, R. Devloo, L. Johnson, D.C. Marks, L. Dumont, K.M. Devreese, H.B. Feys, V. Compernolle
A-140 AN OPEN CONFORMATION OF ADAMTS13 IS A HALLMARK OF ACUTE ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA
E. Roose, A.-S. Schelpe, B.S. Joly, A. Vandenbulcke, I. Pareyn, L. Desender, N. VanDePutte, M. Peetermans, P. Verhamme, J. Voorberg, A. Greinacher, H. Deckmyn, S.F. De Meyer, P. Coppo, A. Veyradier, K. VanHoorelbeke
A-129 UNRAVELING ANTI-SPACER IMMUNOPROFILES OF ACQUIRED TTP PATIENTS USING ANTI-IDIOTYPIC ANTIBODIES
A.-S. Schelpe, E. Roose, F. Peyvandi, B. Joly, I. Pareyn, H. Deckmyn, J. Voorberg, P. Coppo, A. Veyradier, S.F. De Meyer, K. VanHoorelbeke
A-145 PLASMA OF HEALTHY DONORS CONTAINS SPECIFIC ANTI-IDIOTYPIC ANTIBODIES THAT RECOGNIZE TWO CLONED HUMAN ANTI-ADAMTS13 AUTOANTIBODIES
K. Kangro, E. Roose, S. Horta, A.-S. Schelpe, L. Desender, R. Visser, G. Vidarsson, A. Männik, H.B. Feys, H. Deckmyn, S.F. De Meyer, K. VanHoorelbeke
A-137 PHOSPHORYLATION OF ACETYL-COA CARBOXY-LASE BY AMPK IN PLATELETS CONTROLS THROMBOXANE GENERATION, DENSE GRANULES SECRETION AND THROMBUS FORMATION
S. Lepropre, S. Kautbally, L. Bertrand, G.R. Steinberg, B.E. Kemp, A. Hego, O. Wéra, S. Brouns, F. Swieringa, B. Guigas, J. Heemskerk, C. Oury, C. Beauloye, S. Horman
Top
